Ocular myasthenia
Myasthenia gravis is a chronic autoimmune neuromuscular disorder typically presenting with variable skeletal muscle fatigue. The most prevalent initial manifestation of myasthenia is ocular myasthenia. Approximately 50% of all myasthenia cases begin with the weakening of the eye muscles that genera...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Vilnius University Press
2022-09-01
|
Series: | Neurologijos seminarai |
Subjects: | |
Online Access: | https://www.journals.vu.lt/neurologijos_seminarai/article/view/33256 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832593131917279232 |
---|---|
author | J. Zakaravičiūtė M. Šerelytė |
author_facet | J. Zakaravičiūtė M. Šerelytė |
author_sort | J. Zakaravičiūtė |
collection | DOAJ |
description |
Myasthenia gravis is a chronic autoimmune neuromuscular disorder typically presenting with variable skeletal muscle fatigue. The most prevalent initial manifestation of myasthenia is ocular myasthenia. Approximately 50% of all myasthenia cases begin with the weakening of the eye muscles that generally presents as diplopia and/or ptosis. However, about 60% of these cases progress to a generalized type within the first 2 years. The diagnosis of ocular myasthenia is often difficult but is collectively confirmed by clinical evaluation and laboratory results.
Clinical manifestations, diagnostic approach, relevance, and therapeutic options are discussed in this article.
|
format | Article |
id | doaj-art-faf597ab087b44e290ee9ed3b158cd58 |
institution | Kabale University |
issn | 1392-3064 2424-5917 |
language | English |
publishDate | 2022-09-01 |
publisher | Vilnius University Press |
record_format | Article |
series | Neurologijos seminarai |
spelling | doaj-art-faf597ab087b44e290ee9ed3b158cd582025-01-20T18:22:14ZengVilnius University PressNeurologijos seminarai1392-30642424-59172022-09-01262 (92)10.29014/NS.2022.26.8Ocular myastheniaJ. Zakaravičiūtė0M. Šerelytė1Lithuanian University of Health SciencesLithuanian University of Health Sciences Myasthenia gravis is a chronic autoimmune neuromuscular disorder typically presenting with variable skeletal muscle fatigue. The most prevalent initial manifestation of myasthenia is ocular myasthenia. Approximately 50% of all myasthenia cases begin with the weakening of the eye muscles that generally presents as diplopia and/or ptosis. However, about 60% of these cases progress to a generalized type within the first 2 years. The diagnosis of ocular myasthenia is often difficult but is collectively confirmed by clinical evaluation and laboratory results. Clinical manifestations, diagnostic approach, relevance, and therapeutic options are discussed in this article. https://www.journals.vu.lt/neurologijos_seminarai/article/view/33256myastheniaocular myastheniaautoimmuneclinical characteristicsdiagnosistreatment |
spellingShingle | J. Zakaravičiūtė M. Šerelytė Ocular myasthenia Neurologijos seminarai myasthenia ocular myasthenia autoimmune clinical characteristics diagnosis treatment |
title | Ocular myasthenia |
title_full | Ocular myasthenia |
title_fullStr | Ocular myasthenia |
title_full_unstemmed | Ocular myasthenia |
title_short | Ocular myasthenia |
title_sort | ocular myasthenia |
topic | myasthenia ocular myasthenia autoimmune clinical characteristics diagnosis treatment |
url | https://www.journals.vu.lt/neurologijos_seminarai/article/view/33256 |
work_keys_str_mv | AT jzakaraviciute ocularmyasthenia AT mserelyte ocularmyasthenia |